FDA Approves Wegovy® Pill: First Oral GLP-1 for Chronic Weight Management and Cardiovascular Risk Reduction
BAGSVAERD, Denmark – January 2026 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the Wegovy® pill (once-daily oral semaglutide 25 mg). This milestone…









